Last reviewed 2026-06-10 · How we verify

inability to handle stress — Treatment Landscape & Competitive Intelligence

inability to handle stress (disease) competitive landscape: 1 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

Marketed treatment landscape

Approved drugs treating inability to handle stress, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

1. Pro Weight Loss Inc. · 1 drug in inability to handle stress

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in inability to handle stress:

• inability to handle stress treatment updates — RSS
• inability to handle stress treatment updates — Atom
• inability to handle stress treatment updates — JSON

Cite this brief

Drug Landscape (2026). inability to handle stress — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/inability-to-handle-stress. Accessed 2026-06-10.

Related

• inability to handle stress full disease profile — treatment pathway, diagnostics, guidelines
• Browse all CI briefs
• Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing